Gerald Crabtree
Chief Operating Officer chez Viridis Biotech, Inc.
Fortune : - $ au 31/03/2024
Profil
Gerald W.
Crabtree is a member of the American Society of Clinical Oncology, the American Association for Cancer Research, and the Chief Operating Officer of Viridis Biotech, Inc. He was previously the Chief Executive Officer of PhytoCeutica, Inc., the Director of Project Planning & Management at Bristol Myers Squibb Co., the Pharmacology Director at Viratek, Inc., and the Vice President of Research & Development at ETEX Corp.
He is also the Chief Scientific Officer of PharmaCyte Biotech, Inc. Crabtree earned a doctorate degree from the University of Alberta.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMACYTE BIOTECH, INC.
-.--% | 20/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Gerald Crabtree
| Sociétés | Poste | Début |
|---|---|---|
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Viridis Biotech, Inc.
 Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The private company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Chief Operating Officer | - |
Anciens postes connus de Gerald Crabtree
| Sociétés | Poste | Fin |
|---|---|---|
| PHARMACYTE BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 12/10/2022 |
PhytoCeutica, Inc.
 PhytoCeutica, Inc. Medical DistributorsDistribution Services PhytoCeutica, Inc. develops drugs for the treatment of cancer. It focuses on preclinical studies, clinical investigations, and a platform technology to assess botanical quality control and reproducibility. The company was founded by Yale University, Patrick Kung and Dr. Yung-Chi Cheng in 1999 and is headquartered in New Haven. CT. | Chief Executive Officer | 01/01/2010 |
ETEX Corp.
 ETEX Corp. Chemicals: Major DiversifiedProcess Industries Etex Corp. manufactures calcium phosphate biomaterials. Its products are used for bone graft substitutes, reconstruction of skeletal defects, orthopedic, spine indications, and orthopedic implants. The company was founded by D. Duke Lee in 1989 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01/01/2003 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/1997 |
| Viratek, Inc. | Corporate Officer/Principal | 01/01/1990 |
Formation de Gerald Crabtree
| University of Alberta | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PHARMACYTE BIOTECH, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
| Viratek, Inc. | Health Technology |
ETEX Corp.
ETEX Corp. Chemicals: Major DiversifiedProcess Industries Etex Corp. manufactures calcium phosphate biomaterials. Its products are used for bone graft substitutes, reconstruction of skeletal defects, orthopedic, spine indications, and orthopedic implants. The company was founded by D. Duke Lee in 1989 and is headquartered in Cambridge, MA. | Process Industries |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
PhytoCeutica, Inc.
PhytoCeutica, Inc. Medical DistributorsDistribution Services PhytoCeutica, Inc. develops drugs for the treatment of cancer. It focuses on preclinical studies, clinical investigations, and a platform technology to assess botanical quality control and reproducibility. The company was founded by Yale University, Patrick Kung and Dr. Yung-Chi Cheng in 1999 and is headquartered in New Haven. CT. | Distribution Services |
Viridis Biotech, Inc.
Viridis Biotech, Inc. Pharmaceuticals: MajorHealth Technology Part of PharmaCyte Biotech, Inc., Viridis Biotech, Inc. develops biopharmaceutical products for the treatment of chronic diseases. The private company is based in Silver Spring, MD. The CEO of the company is Timothy M. Matula. | Health Technology |
